Phospholipase A2 and Breast Cancer
Author Information
Author(s): S.-I. Yamashita, J.-I. Yamashita, M. Ogawa
Primary Institution: Kumamoto University Medical School
Hypothesis
Is the concentration of group II phospholipase A2 in breast cancer tissues associated with their malignant potential?
Conclusion
Higher levels of M-PLA2 in breast cancer tissues are linked to worse survival outcomes.
Supporting Evidence
- M-PLA2 concentration was significantly higher in patients with distant metastasis.
- Patients with high M-PLA2 concentrations had shorter disease-free and overall survival.
- M-PLA2 was found to be an independent prognostic factor for disease recurrence and death.
Takeaway
This study found that a certain enzyme in breast cancer tissues can help predict how aggressive the cancer is.
Methodology
M-PLA2 concentrations were measured in tissue extracts from breast cancer patients using a radioimmunoassay.
Limitations
The study may have optimistic results due to using the same dataset to determine the cut-off point.
Participant Demographics
Patients who underwent mastectomy for breast cancer between 1982 and 1987.
Statistical Information
P-Value
0.025
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website